Navigation Links
Pharma in Medical News

Sao Paulo Hosts Second CPhI and P-MEC South America Pharma Events

MAARSSEN, Netherlands, Aug. 6 /PRNewswire/ -- Against the background of continuing strong market growth, Sao Paulo will host the second CPhI South America and P-MEC South America pharma ingredients and production technology events on Wednesday 26 - Friday 28 August. Staged by UB...

China Pharma Events Keep Growing For UBM

MAARSSEN, The Netherlands, Aug. 6: /PRNewswire/ -- Numbers were impressive at June's CPhI China , with ICSE China and P-MEC China - which together form Asia 's biggest annual networking opportunity for the pharma ingredients, services and production equipment communities. ...

MultiVu Video Feed: SCIELE PHARMA ANNOUNCES AVAILABILITY OF ULESFIA(TM), FIRST AND ONLY FDA-APPROVED NON-NEUROTOXIC HEAD LICE TREATMENT

Sciele Pharma, Inc., a Shionogi Company, today announced the availability of Ulesfia (Benzyl Alcohol Lotion 5%), the first and only prescription medication that kills head lice by asphyxiation without potential neurotoxic side effects. Approved by the U.S. Food & Drug Administration (FDA),...

URL Pharma Acquires PharmPro Manufacturing Facility and Equipment

PHILADELPHIA, Aug. 3 /PRNewswire/ -- URL Pharma, a leading specialty pharmaceutical company, today announced it has acquired the assets of PharmPro, a division of Fluid Air, Inc. The facility, located in Aurora, Illinois, is FDA inspected and DEA (Drug Enforcement Agency) licensed. The ...

China Pharma Holdings, Inc. to Report Second Quarter 2009 Financial Results on August 12, 2009

HAIKOU CITY, China, July 29 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it plans to release second quarter 2009 financial resul...

aTyr Pharma Raises an Additional $12 Million

SAN DIEGO, July 28 /PRNewswire/ -- aTyr Pharma announced today that it has raised an additional $12 million to fund its discovery operations and development of its lead candidate. The company is discovering and developing biotherapeutics to treat a wide variety of diseases, includi...

Avidas(TM) Pharmaceuticals and LaRon(TM) Pharma Inc. Announce Co-Promotion Agreement

DOYLESTOWN, Pa., July 21 /PRNewswire/ -- Avidas Pharmaceuticals and LaRon Pharma Inc. today announced that they have entered into an agreement for LaRon to co-promote Avidas' key prescription-only convenience kits, Avidoxy(TM) DK defence kit and Scalacort(TM) DK defence kit. Under the te...

Dr. Richard Rosenbloom Resumes Services To The Quigley Corporation's Pharma Subsidiary

DOYLESTOWN, Pa., July 10 /PRNewswire-FirstCall/ -- The Quigley Corporation, (Nasdaq: QGLY ) , www.quigleyco.com , today announced that Dr. Richard Rosenbloom has resumed providing services to the Company's Quigley Pharma subsidiary. Dr. Rosenbloom had been temporarily suspended from t...

MDS Inc. Completes Divestiture of MDS Pharma Services Phase II-IV Operations

MDS Pharma Services to Focus on the Delivery of Early Stage Services - Discovery Through Phase IIa TORONTO, July 1 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: MDZ ), a leading provider of products and services to the global life sciences markets, today announced that it has...

Aton Pharma CEO Mike Wells Named Ernst & Young Entrepreneur Of The Year(R) 2009 Award Winner;

Award Recognizes Entrepreneurial Excellence LAWRENCEVILLE, N.J., June 30 /PRNewswire/ -- Aton Pharma, Inc. announced today that its Chief Executive Officer, Michael G. Wells, has received the Ernst & Young Entrepreneur Of The Year (R) 2009 Award in the emerging companies category in New ...

More>>

Pharma in Medical Technology

New Small and Medium Sized Enterprises Join TI Pharma by Signing Two New Projects

LEIDEN, The Netherlands, July 6 /PRNewswire/ -- Three new small and medium sized enterprises (SMEs) - Syncom, Synvolux Therapeutics and InteRNA Technologies - have joined public-private partnership TI Pharma by participating in two new projects. These projects, focusing on cancer and inflammat...

BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic Dermatitis

TURKU, Finland, July 3 /PRNewswire/ -- BioCis Pharma Ltd., a privately held drug development company with its headquarters in Turku, Finland, announced positive results from its Phase IIa clinical trial of ProtoCure(TM) emulsion cream, the company's novel topical drug for dermatology. This dou...

PARI Pharma Reports Successful Phase Ib Clinical Results for Inhaled Liposomal Cyclosporine A and Gains FDA Orphan Drug Designation for the Prevention and Treatment of Bronchiolitis Obliterans

MONTEREY, Calif., June 2 /PRNewswire/ -- This month's Journal of Aerosol Medicine and Pulmonary Drug Delivery features positive Phase Ib clinical trial results for PARI Pharma's L-CsA, inhaled liposomal cyclosporine A. In May, PARI Pharma received Orphan Drug Designation from the Food and Drug Ad...

BioCis Pharma Starts a Phase I Clinical Trial With a New Cancer Drug

TURKU, Finland, May 28 /PRNewswire/ -- BioCis Pharma Ltd., a privately-held drug development company with its headquarters in Turku, Finland, has started Phase I clinical testing of ProtoCure(TM) intravesical instillation solution, a novel anti-cancer drug for urinary bladder cancer. ProtoCure...

Dainippon Sumitomo Pharma Announces Lurasidone Phase III Data in Patients With Schizophrenia

- The company plans to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration in 2010 - SAN FRANCISCO, May 20 /PRNewswire/ -- Dainippon Sumitomo Pharma Co., Ltd., (DSP) announced today positive results from the first phase 3 clinical trial for lurasidone, which is under ...

Tris Pharma Announces Acceptance of Its First Two NDAs

- First ever 24 hour oral liquid sustained release formulation submitted to the FDA - Validates OralXR(TM) technology platform - eliminates the need to swallow pills by providing sustained release in liquids, chewable tablets, and films - Upon approval will provide both liquid and tablet...

Cystic Fibrosis - Orphan Drug Designation for Innovative Treatment Against Lung Infections by Axentis Pharma AG

ZURICH, Switzerland, April 30 /PRNewswire/ -- An innovative treatment for infections of the respiratory tract in cystic fibrosis patients has received orphan drug designation in the US. Axentis Pharma of Zurich, Switzerland announced today that this sought-after designation has been granted to...

Novagali Pharma Completed a New Phase II With Cyclokat(R) in Dry Eye

EVRY, France, April 15 /PRNewswire/ -- Novagali Pharma, a French pharmaceutical ophthalmic company, today announces successful completion of a new Phase II clinical study with Cyclokat(R), its formulation of Cyclosporine. The results demonstrate statistically significant improvement with signs...

Novagali Pharma Presents Results of its Innovative Latanoprost Formulation for Glaucoma

EVRY, France, February 27 /PRNewswire/ -- Novagali Pharma, a French pharmaceutical ophthalmic company, announced the results of its first set of data pertaining to Nova21027, its innovative BAK-free latanoprost formulation for glaucoma. Novagali communicated about "Ocular safety compari...

Archimedes Pharma Announces Successful Proof-of-Concept Results on Two Intranasal Development Projects

READING, England, February 26 /PRNewswire/ -- - Intranasal Apomorphine for the Treatment of Motor Fluctuations in Advanced Parkinson's Disease - Intranasal Diazepam for the Treatment of Acute Repetitive Seizures in Epilepsy - Phase II Trials on Both Projects to be Initiate...

More>>

Pharma in Biological News

Boost from McGill, Gates Foundation helps Africans control pharma research

This release is available in French . A McGill University parasitology researcher has received a $100,000 grant from the Gates Foundation to help establish locally controlled pharmaceutical-research programs in Botswana and South Africa. "People are always asking why the pharmaceutica...

Biotech Co. founded by UCLA Scientists to be acquired by Astellas, Pharma Inc.

A business success story has both UCLA and a team of enterprising UCLA scientists envisioning a brighter future for cancer research and patient care. In 1996, a unique collaboration of leading UCLA scientists led by Dr. Arie Belldegrun founded the biotechnology company Agensys Inc. and the c...

Martin Hensen, head of e-strategies, UCB Germany: Making e-marketing more than just an add-on

..., reminds him of Web 2.0. But he questions whether pharma is ready for Web 2.0. The health system is 100% regulated, Hensen says, making it Health 1.0. But pharma itself is no better. He says with content needing ...sites and more people in Legal than in e-Business, pharma companies themselves are still at...

DuoCort: New chronotherapy for adrenal insufficiency

... the USA. The new product, a once daily dual-release hydrocortisone oral tablet that comes in both 5 mg and 20 mg sizes, is being developed by DuoCort pharma AB, a wholly-owned subsidiary. For more information on DuoCort please visit www.duocort.com Contact information Medical spokesperson: Gudmundur Joh...

New supplement may help slow sight loss in elderly

...he advice of Professor Ian Young from the School of Medicine, Dentistry and Biomedical Sciences at Queen's and scientists in eyecare companies Dr Mann pharma and Bausch and Lomb. AMD is an incurable eye disease which causes blurring of central vision because of its effects on the macula, the central part ...

Amarna Therapeutics B.V. and TNO announce SVac research and development partnership

...ders. The base of Amarna’s therapeutics is the SVac viral gene delivery vector platform, which provides sensational characters unheard of in the pharma arena, creating opportunities to serve markets with enormous potential due to clinical unmet needs. About SVac Our SVac viral gene delivery vec...

American Chemical Society's Weekly PressPac -- May 20, 2009

...ent. No drug companies lost money, but double digit earnings declines at some top firms raised warning flags. For a free copy of this C&EN story about pharma companies' economic problems, send an e-mail to m_bernstein@acs.org . ACS pressroom blog The American Chemical Society's Office of Public Affai...

Prefilled WFI Syringe Provides a High-Quality Solution for Drug Reconstitution

...and other jurisdictions.  MixJect® is a registered trademark of Medimop Medical Projects Inc. For more information contact  Vetter pharma International GmbH Oskar Gold Eywiesenstrasse 5 88212 Ravensburg Germany phone: +49-(0)751-3700 - 0 fax: +49-(0)751-3700 - 40 00 e-mail:...

Former NASA astronaut Bonnie J. Dunbar to speak at NJIT's biomedical engineering seminar

...to the world of flight. The event will be held at 11:30 a.m., on Thursday, April 23, 2009, in 118 Kupfrian Hall. Event sponsors include Purdue pharma L.P. and Bristol-Myers Squibb Company. Dr. Bonnie J. Dunbar is currently president and CEO of The Museum of Flight in Seattle,Washington. The "MOF"...

In troubled economic times, BioSquare 2009 successfully serves as business and innovation starter

... the 343 companies in attendance, including 11 big pharma companies, held some 2,500 business meetings. The ...difficult economic context by offering biotech and pharma company managers a solid chance to develop busines...ncreasingly high-performance diagnostic tools. The pharma industry and the biotechs are therefore working to...
Pharma in Biological Technology

Laureate Pharma Appoints Daniel E. Leone as Vice President of Business Development

PRINCETON, N.J., July 28 /PRNewswire/ -- Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced the appointment of Daniel E. Leone as Vice President of Business Development. Mr. Leone will be responsible for Laureate's worldwid...

Big Pharma to Big Biopharma: Frost & Sullivan Examines the Latest M&A Trends and Opportunities

London, July 20 /PRNewswire/ -- There has been a recent upsurge in Merger & Acquisition (M&A) activities in the pharmaceutical and biotechnology space. While the economic downturn and related credit crunch has had an impact, this alone cannot account for the recent M&A mania,...

Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009

HORSHOLM, Denmark, July 14 /PRNewswire/ -- The Board of Directors of Santaris Pharma has approved the Interim Report for the period 1 January to 30 June 2009. - The loss after tax realised in the 2nd quarter of 2009 was 21,6m DKK (2,9m EUR) compared to 29,8m DKK (4,0m EUR) in the...

Celtic Pharma Holdings Announces Investment in Novacta Biosystems Limited

ST PETER PORT, Guernsey and LONDON, July 6 /PRNewswire/ -- - GBP13.1 Million Funding to Drive Novel Antibiotics Platform Addressing Areas of Major Unmet Need, Including Hospital Acquired Infections C. Difficile and MRSA Celtic Pharma Holdings Advisors LLP ("CPHA"), the advisor to...

Clavis Pharma Raises NOK 129 Million (USD 20 Million) in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug Candidates

OSLO, Norway, June 26 /PRNewswire-FirstCall/ -- Clavis Pharma ASA (OSE: CLAVIS) today announced that the Company has raised NOK 129 million (equivalent to USD 20 million) in gross proceeds through a private placement of 10,750,000 new shares, each with a par value of NOK 1.00 at a price of NOK...

Dragon Pharma Announces Results of 2009 Annual General Meeting

VANCOUVER, June 22 /PRNewswire-FirstCall/ - Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company, today announced the results of the Annual Shareholders Meeting held on June 21, 2009 in Hong Kong, China. Th...

Mexico Premiere for Money-Saving Pharma Leak Testing Equipment

Sepha Ltd's ergonomically designed leak testing machines for the Central American pharmaceutical packaging industry makes premiere appearance at Expo Pack 2009, Mexico City on 23-26 June. BLISTERSCAN, PRESS-OUT UNIVERSAL and PRESS-OUT MANUAL will be in action at Expo Pack and the Sepha team w...

Scripps Research Institute Highlights Groundbreaking Work of aTyr Pharma Scientific Co-Founder

Research Published by Scripps Associate Professor Xiang-Lei Yang Further Validates aTyr Pharma's Discovery Engine for Proprietary Drugs SAN DIEGO, June 8 /PRNewswire/ -- The June 1st, 2009 edition of The Scripps Research Institute (TSRI) News & Views highlights newly published researc...

Santaris Pharma Director Appointed Adjunct Professor in RNA Biology at the University of Aalborg, Denmark

COPENHAGEN, June 3 /PRNewswire/ -- Santaris Pharma and Copenhagen Institute of Technology, Aalborg University, Denmark, announced today that Director of microRNA, Santaris Pharma, Sakari Kauppinen, has been appointed Adjunct Professor in RNA Biology at Copenhagen Institute of Technology. The a...

2009 Pharma ChemOutsourcing Show Attendance Up an Astounding 60% Despite Current Recession

LONG BRANCH, N.J., June 3 /PRNewswire/ -- The 2009 Pharma ChemOutsourcing Conference & Exhibition attendance is way up again in 2009 and is poised to shatter the attendance record set in 2008. The remarkable success of last year's meeting generated the positive buzz responsible for much of th...

More>>

Pharma in Biological Definition

Malaria

...a are under development, with no completely effective vaccine yet available (as of November 2004 ). A team backed by the Gates Foundation and the pharma giant GlaxoSmithKline announced a partially successful field trial in October 2004 , for RTS,S/AS02A , a vaccine which reduces infection risk by...
Pharma in Biological Dictionary

Dendrite

...es. 5 External links ... Retrieved from "http://en.wikipedia.org /wiki/ Dendrite " ... Cegedim Dendrite is the worldwide leader in pharma CRM and Data Solutions for the Pharmaceutical Industry. ... Cegedim Dendrite's Laurent Schockmel Named to ... (Click to enlarge) dendrite ( Sch...

Allosteric site

...aves the regulatory site . ... Allosteric Site - BioPortfolio - Indepth ... Biochemistry: Jul 13 2009 5:03PM Matching: allosteric site ... pharma Live: Jun 29 2009 8:58AM Matching: allosteric site ... ALLOSTERIC SITE OF SCCM. CONFORMATIONS OF SCCM ... UTP can bind to the allosteric ...
Other Tags
(Date:7/23/2014)... Battle Creek, MI (PRWEB) July 23, 2014 ... treatment program that gets clients off to a great ... they can believe in, has launched a new Internet ... , “Many people are surprised to learn that Internet ... sexual addiction or drug addiction, but that it’s trapping ...
(Date:7/23/2014)... Adipic acid is an intermediate chemical ... plastic, often referred to as engineering thermoplastics. These ... the monomers employed. Due to the high production ... increasing number of developing countries, the Asia-Pacific region ... by Europe and North America. Adipic acid in ...
(Date:7/23/2014)... 23, 2014 (HealthDay News) -- Children and teens who lose ... death in adulthood, a new study suggests. People who ... 50 percent greater risk of death during the study period ... parent, according to the report. Although the study found ... risk of premature death, it wasn,t designed to prove cause-and-effect. ...
(Date:7/23/2014)... ill patients arriving at the emergency department, the ... amnesia for rapid, life-saving intubation, despite decades-old studies ... results of a systematic review of 10 recent ... a "wonder drug" are published online in ... of Ketamine on Intracranial and Cerebral Perfusion Pressure ...
(Date:7/23/2014)... 2014 SafeUseNow? , a ... developed by Principled Strategies , today announced ... California . Utilizing SafeUseNow’s patent-pending risk model, Partnership ... misusing and abusing controlled substance drugs, particularly prescription ... its members. , The agreement with Partnership HealthPlan ...
Breaking Medicine News(10 mins):Health News:Latest A Forever Recovery Launches Internet Addiction Section on Website 2Health News:North America Adipic Acid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 2Health News:North America Adipic Acid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 3Health News:North America Adipic Acid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 4Health News:Parent's Death May Raise Risk of Early Death for Grown Children, Study Suggests 2Health News:Ketamine can be a wonder drug for ER patients and their physicians 2Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 2Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 3Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 4
(Date:7/23/2014)... disease, the devastating neurological disease affecting more than ... new progress on a set of compounds, initially ... a potential oral therapy for Alzheimer,s. Their study ... . , Carlo Ballatore, Kurt R. Brunden and ... protein known as tau binds to and stabilizes ...
(Date:7/23/2014)... and blood-brain barrier damage appear after cerebral ... Matrix metalloproteinase-9 is able to degrade the ... cerebral blood vessels and to mediate extracellular ... colleagues from the First Affiliated Hospital of ... induced cerebral infarction in stroke-prone spontaneously hypertensive ...
(Date:7/23/2014)... is available in German . ... Max Planck Institute of Molecular Cell Biology and ... capture detailed three-dimensional images of cardiac dynamics in ... Plane Illumination Microscopy (SPIM) and clever image processing ... heart. Furthermore, they have developed a method of ...
Breaking Biology News(10 mins):Unbreak my heart 2
Other Contents